Active Not RecruitingNCT05088356
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
PHASE1 · 66 planned enrolment
- Countries listed
- 1
- Registry update
- May 12, 2026
immortal.lifeTrial registrations containing the exact intervention label tacrolimus.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · 66 planned enrolment
PHASE3 · 304 planned enrolment